141 related articles for article (PubMed ID: 37982578)
21. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
[TBL] [Abstract][Full Text] [Related]
22. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
[TBL] [Abstract][Full Text] [Related]
23. Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer.
Ferguson HJ; Wragg JW; Ward S; Heath VL; Ismail T; Bicknell R
Oncotarget; 2016 Apr; 7(15):20440-54. PubMed ID: 26943033
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
25. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
[TBL] [Abstract][Full Text] [Related]
26. Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation.
Niu Z; Zhang W; Shi J; Li X; Wu H
J Cardiothorac Surg; 2021 Jul; 16(1):194. PubMed ID: 34233689
[TBL] [Abstract][Full Text] [Related]
27. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway.
Zhang L; Liang H; Xin Y
Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-124 inhibits proliferation and metastasis of esophageal cancer via negatively regulating NRP1.
Zang RK; Ma JB; Liang YC; Wang Y; Hu SL; Zhang Y; Dong W; Zhang W; Hu LK
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4532-4541. PubMed ID: 30058693
[TBL] [Abstract][Full Text] [Related]
29. Estrogen regulates the expression of N-methyl-D-aspartate (NMDA) receptor subunit epsilon 4 (Grin2d), that is essential for the normal sexual behavior in female mice.
Ikeda K; Fukushima T; Ogura H; Tsukui T; Mishina M; Muramatsu M; Inoue S
FEBS Lett; 2010 Feb; 584(4):806-10. PubMed ID: 20067795
[TBL] [Abstract][Full Text] [Related]
30. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
31. An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma.
Pan J; Tao YF; Zhou Z; Cao BR; Wu SY; Zhang YL; Hu SY; Zhao WL; Wang J; Lou GL; Li Z; Feng X; Ni J
J Transl Med; 2011 Sep; 9():157. PubMed ID: 21936950
[TBL] [Abstract][Full Text] [Related]
32. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
33. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
[TBL] [Abstract][Full Text] [Related]
34. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
[TBL] [Abstract][Full Text] [Related]
35. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
[TBL] [Abstract][Full Text] [Related]
36. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
Liang Y; Li S
Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
[TBL] [Abstract][Full Text] [Related]
37. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
Yang F; Sun Z; Wang D; Du T
BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.
Tasioudi KE; Sakellariou S; Levidou G; Theodorou D; Michalopoulos NV; Patsouris E; Korkolopoulou P; Saetta AA
APMIS; 2015 Aug; 123(8):639-47. PubMed ID: 25912437
[TBL] [Abstract][Full Text] [Related]
39. ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer.
He F; Xiao H; Cai Y; Zhang N
Cell Commun Signal; 2021 May; 19(1):53. PubMed ID: 33980247
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma.
Huhta H; Helminen O; Lehenkari PP; Saarnio J; Karttunen TJ; Kauppila JH
Oncotarget; 2016 Apr; 7(17):23658-67. PubMed ID: 27008696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
